Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
9.18
+0.62 (7.24%)
At close: Jul 9, 2025

RAJAF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,020917----
Enterprise Value
1,021917----
Last Close Price
9.188.25----
PS Ratio
813.80731.35----
PB Ratio
-2716.28-2441.10----
P/OCF Ratio
3269.432938.21----
EV/Sales Ratio
-731.89----
EV/EBITDA Ratio
-3820.26----
Debt / Equity Ratio
-1.46-1.46-4.13-0.62-8.13-133.88
Debt / EBITDA Ratio
1.661.661.72-65.3732.33
Debt / FCF Ratio
--15.60---
Asset Turnover
0.310.310.320.02--
Quick Ratio
0.010.010.010.010.160.00
Current Ratio
0.120.120.110.200.390.39
Return on Assets (ROA)
-2.88%-2.88%5.22%-9.67%-2.45%-
Return on Capital (ROIC)
-35.48%-35.48%244.33%-32.28%-4.07%-
Return on Capital Employed (ROCE)
--59.10%--3.20%
Earnings Yield
-0.02%-0.03%----
FCF Yield
-0.00%-0.00%----
Buyback Yield / Dilution
-11.12%--6.42%-4.42%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.